{"DataElement":{"publicId":"2755631","version":"1","preferredName":"American College of Surgeons Oncology Group Person Exclusion Criteria Clinical Trial Eligibility Criteria Type","preferredDefinition":"the elements of a personal medical history which preclude an individual from participating in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI whose primary goal is to evaluate surgical therapies in the management of patients with malignant solid tumors.","longName":"ACOSOG_PER_EXC_CT_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2755583","version":"1","preferredName":"American College of Surgeons Oncology Group Person Exclusion Criteria Clinical Trial Eligibility Criteria","preferredDefinition":"information relating to the elements of a personal medical history which preclude an individual from participating in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI whose primary goal is to evaluate surgical therapies in the management of patients with malignant solid tumors.","longName":"ACOSOG_PER_EXCL_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2755579","version":"1","preferredName":"American College of Surgeons Oncology Group Person","preferredDefinition":"The American College of Surgeons Oncology Group (ACOSOG) is a cooperative group sponsored by the NCI whose primary goal is to evaluate surgical therapies in the management of patients with malignant solid tumors. The ACOSOG (Durham, NC) includes general and specialty surgeons, representatives of related oncologic disciplines and allied health professionals in academic medical centers and community practices throughout the US and foreign countries. The group is composed of the Administrative Coordinating Center and the Statistics and Data Coordinating. Both groups are based at the Duke Clinical Research Institute.:Person; a human being.","longName":"C19712:C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"American College of Surgeons Oncology Group","conceptCode":"C19712","definition":"A cooperative group sponsored by the NCI whose primary goal is to evaluate surgical therapies in the management of patients with malignant solid tumors. The ACOSOG (Durham, NC) includes general and specialty surgeons, representatives of related oncologic disciplines and allied health professionals in academic medical centers and community practices throughout the US and foreign countries. The group is composed of the Administrative Coordinating Center and the Statistics and Data Coordinating. Both groups are based at the Duke Clinical Research Institute.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC3FFC2-8A3A-61F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518232","version":"1","preferredName":"Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"Exclusion; the act of restricting entrance or barring from participation.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25370:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exclusion Criteria","conceptCode":"C25370","definition":"Medical and/or social characteristics that prevent a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC88111-1844-69E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC3FFC2-8A5A-61F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2755630","version":"1","preferredName":"ACOSOG 1041 Exclusion Criteria Type","preferredDefinition":"the exclusion criteria for ACOSOG 1041.","longName":"ACOSOG 1041_ECL_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Patient has history of ipsilateral DCIS treated with radiation therapy","valueDescription":"Patient has history of ipsilateral DCIS treated with radiation therapy","ValueMeaning":{"publicId":"2755632","version":"1","preferredName":"Patient has history of ipsilateral DCIS treated with radiation therapy","longName":"2755632","preferredDefinition":"Patient has history of ipsilateral DCIS treated with radiation therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC6451D-E40F-25CA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC6325E-E1FF-26DA-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"CAMPBELB","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient has had surgical axillary staging procedure prior to study entry (excluding FNA of axillary nodes)","valueDescription":"Patient has had surgical axillary staging procedure prior to study entry (excluding FNA of axillary nodes)","ValueMeaning":{"publicId":"2755633","version":"1","preferredName":"Patient has had surgical axillary staging procedure prior to study entry (excluding FNA of axillary nodes)","longName":"2755633","preferredDefinition":"Patient has had surgical axillary staging procedure prior to study entry (excluding FNA of axillary nodes)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC647F5-F836-237C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61B22-E8FC-242F-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient has tumor clinically staged as T4","valueDescription":"Patient has tumor clinically staged as T4","ValueMeaning":{"publicId":"2755637","version":"1","preferredName":"Patient has tumor clinically staged as T4","longName":"2755637","preferredDefinition":"Patient has tumor clinically staged as T4","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC62420-8E4C-2454-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61B22-E90E-242F-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient has ipsilateral cN2b or cN3 disease","valueDescription":"Patient has ipsilateral cN2b or cN3 disease","ValueMeaning":{"publicId":"2755636","version":"1","preferredName":"Patient has ipsilateral cN2b or cN3 disease","longName":"2755636","preferredDefinition":"Patient has ipsilateral cN2b or cN3 disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC64B19-111C-2427-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61B22-E920-242F-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient has definitive clinical or radiological evidence of metastatic disease","valueDescription":"Patient has definitive clinical or radiological evidence of metastatic disease","ValueMeaning":{"publicId":"2755635","version":"1","preferredName":"Patient has definitive clinical or radiological evidence of metastatic disease","longName":"2755635","preferredDefinition":"Patient has definitive clinical or radiological evidence of metastatic disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC611AC-7BD1-2318-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61B22-E932-242F-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient has prior history of invasive breast cancer","valueDescription":"Patient has prior history of invasive breast cancer","ValueMeaning":{"publicId":"2755634","version":"1","preferredName":"Patient has prior history of invasive breast cancer","longName":"2755634","preferredDefinition":"Patient has prior history of invasive breast cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC64B19-110C-2427-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61B22-E944-242F-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient received treatment for this breast cancer prior to study entry (excluding hormonal therapy that ended before study entry)","valueDescription":"Patient received treatment for this breast cancer prior to study entry (excluding hormonal therapy that ended before study entry)","ValueMeaning":{"publicId":"2755642","version":"1","preferredName":"Patient received treatment for this breast cancer prior to study entry (excluding hormonal therapy that ended before study entry)","longName":"2755642","preferredDefinition":"Patient received treatment for this breast cancer prior to study entry (excluding hormonal therapy that ended before study entry)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC61F5B-47B8-2316-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61695-60A1-23EB-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient is receiving therapy with ANY hormonal agent (excluding medication discontinued before study entry)","valueDescription":"Patient is receiving therapy with ANY hormonal agent (excluding medication discontinued before study entry)","ValueMeaning":{"publicId":"2755641","version":"1","preferredName":"Patient is receiving therapy with ANY hormonal agent (excluding medication discontinued before study entry)","longName":"2755641","preferredDefinition":"Patient is receiving therapy with ANY hormonal agent (excluding medication discontinued before study entry)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC62420-8E5C-2454-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61695-60B3-23EB-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient had prior therapy with anthracyclines or taxanes for any malignancy","valueDescription":"Patient had prior therapy with anthracyclines or taxanes for any malignancy","ValueMeaning":{"publicId":"2755640","version":"1","preferredName":"Patient had prior therapy with anthracyclines or taxanes for any malignancy","longName":"2755640","preferredDefinition":"Patient had prior therapy with anthracyclines or taxanes for any malignancy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC64B19-112C-2427-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61695-60C5-23EB-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient has non-malignant systemic disease that would preclude treatment with either regimen","valueDescription":"Patient has non-malignant systemic disease that would preclude treatment with either regimen","ValueMeaning":{"publicId":"2755639","version":"1","preferredName":"Patient has non-malignant systemic disease that would preclude treatment with either regimen","longName":"2755639","preferredDefinition":"Patient has non-malignant systemic disease that would preclude treatment with either regimen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC61D83-483B-23F9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61695-60D7-23EB-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient has cardiac disease that would preclude the use of epirubicin or trastuzumab","valueDescription":"Patient has cardiac disease that would preclude the use of epirubicin or trastuzumab","ValueMeaning":{"publicId":"2755638","version":"1","preferredName":"Patient has cardiac disease that would preclude the use of epirubicin or trastuzumab","longName":"2755638","preferredDefinition":"Patient has cardiac disease that would preclude the use of epirubicin or trastuzumab","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC619B1-93CF-23E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61695-60E9-23EB-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient has sensory/ motor neuropathy >= grade 2 as defined by CTCAE v3.0","valueDescription":"Patient has sensory/ motor neuropathy >= grade 2 as defined by CTCAE v3.0","ValueMeaning":{"publicId":"2755648","version":"1","preferredName":"Patient has sensory/ motor neuropathy >= grade 2 as defined by CTCAE v3.0","longName":"2755648","preferredDefinition":"Patient has sensory/ motor neuropathy >= grade 2 as defined by CTCAE v3.0","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC66081-A7AA-21D8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC611E7-D98E-2333-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient has had administration of any investigational agents within 30 days prior to study entry","valueDescription":"Patient has had administration of any investigational agents within 30 days prior to study entry","ValueMeaning":{"publicId":"2755647","version":"1","preferredName":"Patient has had administration of any investigational agents within 30 days prior to study entry","longName":"2755647","preferredDefinition":"Patient has had administration of any investigational agents within 30 days prior to study entry","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC66081-A79A-21D8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC611E7-D9A0-2333-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient of child-bearing potential does not have negative urine/ serum pregnancy test within 2 weeks of registration or patient is breast feeding","valueDescription":"Patient of child-bearing potential does not have negative urine/ serum pregnancy test within 2 weeks of registration or patient is breast feeding","ValueMeaning":{"publicId":"2755645","version":"1","preferredName":"Patient of child-bearing potential does not have negative urine/ serum pregnancy test within 2 weeks of registration or patient is breast feeding","longName":"2755645","preferredDefinition":"Patient of child-bearing potential does not have negative urine/ serum pregnancy test within 2 weeks of registration or patient is breast feeding","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC647F5-F846-237C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC611E7-D9B2-2333-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient has psychiatric or addictive disorder or any other condition that, in the investigator?s opinion, precludes patient from meeting eligibility requirements","valueDescription":"Patient has psychiatric or addictive disorder or any other condition that, in the investigator?s opinion, precludes patient from meeting eligibility requirements","ValueMeaning":{"publicId":"2755644","version":"1","preferredName":"Patient has psychiatric or addictive disorder or any other condition that, in the investigator?s opinion, precludes patient from meeting eligibility requirements","longName":"2755644","preferredDefinition":"Patient has psychiatric or addictive disorder or any other condition that, in the investigator?s opinion, precludes patient from meeting eligibility requirements","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC61695-60F4-23EB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC611E7-D9C4-2333-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient has synchronous invasive breast cancer","valueDescription":"Patient has synchronous invasive breast cancer","ValueMeaning":{"publicId":"2755643","version":"1","preferredName":"Patient has synchronous invasive breast cancer","longName":"2755643","preferredDefinition":"Patient has synchronous invasive breast cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC611AC-7BE1-2318-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC611E7-D9D6-2333-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC6325E-E1EB-26DA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Exclusion Criteria","url":null,"context":"CTEP"}],"origin":"ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC611E7-D975-2333-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"CAMPBELB","dateModified":"2008-06-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}